Science To Consumers Analysis
| BEUTDelisted Stock | USD 0.0001 0.00 0.00% |
Science To's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Science To's financial risk is the risk to Science To stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Science To's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Science To is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Science To to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Science To is said to be less leveraged. If creditors hold a majority of Science To's assets, the Company is said to be highly leveraged.
Science To Consumers is overvalued with Real Value of 8.5E-5 and Hype Value of 1.0E-4. The main objective of Science To pink sheet analysis is to determine its intrinsic value, which is an estimate of what Science To Consumers is worth, separate from its market price. There are two main types of Science To's stock analysis: fundamental analysis and technical analysis.
The Science To pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Science |
Science Pink Sheet Analysis Notes
About 66.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.0. Science To Consumers had not issued any dividends in recent years. The entity had 7:1 split on the 19th of August 2014. Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name and distributing Argan oil products. Science to Consumers, Inc. was founded in 2013 and is based in Guangzhou, China. Science To is traded on OTC Exchange in the United States.The quote for Science To Consumers is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Science To Consumers please contact the company at 86 139 0225 5701 or go to http://www.sciencetoconsumers.com.Science To Consumers Investment Alerts
| Science To Consumers is not yet fully synchronised with the market data | |
| Science To Consumers generated a negative expected return over the last 90 days | |
| Science To Consumers has some characteristics of a very speculative penny stock | |
| Science To Consumers has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Science To until it has trouble settling it off, either with new capital or with free cash flow. So, Science To's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Science To Consumers sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Science to invest in growth at high rates of return. When we think about Science To's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (58.7 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Science To Consumers currently holds about 1.44 K in cash with (47.69 K) of positive cash flow from operations. | |
| Roughly 66.0% of the company shares are held by company insiders |
Science Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Science To's market, we take the total number of its shares issued and multiply it by Science To's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Science To Consumers Debt to Cash Allocation
The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Science To until it has trouble settling it off, either with new capital or with free cash flow. So, Science To's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Science To Consumers sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Science to invest in growth at high rates of return. When we think about Science To's use of debt, we should always consider it together with cash and equity.Science To Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Science To's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Science To, which in turn will lower the firm's financial flexibility.About Science Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Science To prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Science shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Science To. By using and applying Science Pink Sheet analysis, traders can create a robust methodology for identifying Science entry and exit points for their positions.
Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name and distributing Argan oil products. Science to Consumers, Inc. was founded in 2013 and is based in Guangzhou, China. Science To is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Science To to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Science Pink Sheet
If you are still planning to invest in Science To Consumers check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science To's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |